There is still no firm guidance as to when Pharming will submit a Rhucin BLA to the FDA; all Pharming is promising is a pre-BLA meeting with the FDA by the end of 2009.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”